MICHELLE JACKSON: Open Payments
NPI 1790347722 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 74 payments from 16 companies in 2025. Trend: 2023 $1,172 · 2024 $1,844 · 2025 $1,288
Food & beverage: $1,288
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $254 |
| ABBVIE INC. | 12 | $209 |
| PFIZER INC. | 8 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $98 |
| Novo Nordisk Inc | 5 | $95 |
| Lilly USA, LLC | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $37 |
Products named: VRAYLAR, FARXIGA, Kerendia, ELIQUIS, CAPLYTA, REXULTI, AIRSUPRA, Wegovy.
Industry payments across IL — which companies pay providers there.
